Value Assessment and Health Outcomes Research Scientific Advisory Committee

Eberechukwu Onukwugha, MS, PhD (Chair)

Executive Director, Pharmaceutical Research Computing
Associate Professor, Dept. of Pharmaceutical Health Services Research

University of Maryland School of Pharmacy

Junling Wang, PhD (Co-Chair)

Professor & Vice Chair for Research
Dept. of Clinical Pharmacy & Translational Science
College of Pharmacy

University of Tennessee

Aasthaa Bansal, PhD

Associate Professor, Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute

University of Washington

Benjamin Craig, PhD

Associate Professor of Economics

University of South Florida

Elizabeth Franklin, PhD, MSW

Head, US Public Affairs and Patient Advocacy, Oncology

Sanofi

Jan Hansen, PhD

Vice President, Evidence for Access Unit
US Medical Affairs

Genentech

Marianne Laouri, PhD

Executive Director, Value Demonstration Team

Boehringer Ingelheim Pharmaceuticals, Inc.

Pei-Jung “Paige” Lin, PhD

Associate Professor of Medicine
Center for the Evaluation of Value & Risk in Health, Institute for Clinical Research & Health Policy Studies

Tufts Medical Center

R. Brett McQueen, PhD

Associate Professor
Skaggs School of Pharmacy

University of Colorado

Philip Naughten, PharmD

Vice President, HEOR

Takeda

Christian Nguyen, PharmD, MBA, MS

Vice President, Global Patient Outcomes and Real World Evidence

Eli Lilly and Company

Megan O’Brien, PhD

Associate Vice President, CORE

Merck

Shelby D. Reed, PhD, RPh

Professor, Depts. of Medicine and Population Health Sciences
Director, Preference Evaluation Research
Group, Center for Informing Health Decisions
Duke Clinical Research Institute

Duke University

Sarah E. Tom, PhD, MPH

Assistant Professor of Epidemiology

Columbia University

Tatia Woodward

Vice President
Value and Evidence Strategy Lead

Pfizer

Gergana Zlateva, PhD

Vice President, Patient & Health Impact, Oncology

Pfizer